Single-Point Periorbital Botulinum Neurotoxin Injection and Its Potential Role in Hematoma Risk Reduction: A Technical Report.

Gardetto A, Thaler-Wolf L.

Open source

DOI
10.3390/toxins18080328
Published
2026-07-28
Container
Toxins (Basel)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/toxins18080328,
  title = {Single-Point Periorbital Botulinum Neurotoxin Injection and Its Potential Role in Hematoma Risk Reduction: A Technical Report.},
  author = {Gardetto A and  Thaler-Wolf L.},
  year = {2026},
  journal = {Toxins (Basel)},
  doi = {10.3390/toxins18080328},
  url = {https://doi.org/10.3390/toxins18080328}
}

RIS

TY  - JOUR
TI  - Single-Point Periorbital Botulinum Neurotoxin Injection and Its Potential Role in Hematoma Risk Reduction: A Technical Report.
AU  - Gardetto A
AU  -  Thaler-Wolf L.
PY  - 2026
JO  - Toxins (Basel)
DO  - 10.3390/toxins18080328
UR  - https://doi.org/10.3390/toxins18080328
ER  - 

APA

A, G., & L., T. (2026). Single-Point Periorbital Botulinum Neurotoxin Injection and Its Potential Role in Hematoma Risk Reduction: A Technical Report.. Toxins (Basel). https://doi.org/10.3390/toxins18080328

Source records